States crack down on Almont-Kid syrup after lab finds deadly ethylene glycol

The syrup containing levocetirizine dihydrochloride and montelukast sodium has been declared “Not of Standard Quality” (NSQ) by the Central Drugs Laboratory (CDL), Kolkata, after tests detected life-threatening contaminants, including toxic ethylene glycol at levels nearly fifteen times the permissible safety limit. The cough syrup, manufactured by Tridus Remedies based in Bihar’s Vaishali district, is prescribed…

Read More

Govt mulls extension for pharma new manufacturing practice norms to bail out small firms

In December 2023, the government had amended the Drugs Rules 1945, revising Schedule M to mandate stricter quality control, equipment standards, and premises requirements. While 2,000 large manufacturers, with turnovers exceeding 250 crore, complied with the revised GMP guidelines by June 2024, the smaller firms were given until 31 December 2025, to upgrade their systems….

Read More